Literature DB >> 31165995

Direct cost of hysterectomy: comparison of robotic versus other routes.

Bilal Kaaki1,2, Emma Lewis3, Sukruta Takallapally4, Benjamin Cleveland5.   

Abstract

The aim of this study was to investigate the direct cost of robotic hysterectomy in comparison with abdominal, vaginal, and laparoscopic routes past the initial learning curve. We examined a consecutive case series of 348 patients undergoing abdominal (AH), vaginal (VH), laparoscopic (LH), or robotic hysterectomy (RH) for benign conditions between January 2015 and March 2017. The primary outcome was the direct cost of hysterectomy, while the secondary outcome was length of stay. Multiple linear regression was used to examine the cost and length of stay across the four hysterectomy groups after controlling for potential confounding variables. 19 (5.5%) patients underwent AH, 53 (15.2%) LH, and 59 (16.9%) VH, while 217 (62.4%) RH. VH group was the oldest at age 52.1 years (p < 0.01), whereas AH group had the highest BMI at 35.9 kg/m2 (p = 0.03). While colporrhaphy was most frequently performed in VH (81%), mid-urethral sling was most common in RH (30%) (p < 0.01). The average direct cost was $3865 for RH, $4063 for AH, $2791 for VH, and $3818 for LH. Upon multivariate analysis, RH and VH were $650.47 (p < 0.01) and $883.07 (p < 0.01) cheaper, respectively, compared to AH. The average length of stay was the shortest for RH at 10.7 h, followed by LH at 15.5 h, vaginal at 20 h, and abdominal at 51.5 h (p < 0.01). VH has the lowest direct cost, while AH has the highest. Both VH and RH have a significantly lower cost than that of AH. RH has the shortest hospital stay, whereas AH has the longest.

Entities:  

Keywords:  Direct cost; Hysterectomy; Length of stay; Robotic surgery

Year:  2019        PMID: 31165995     DOI: 10.1007/s11701-019-00982-7

Source DB:  PubMed          Journal:  J Robot Surg        ISSN: 1863-2483


  1 in total

1.  Healthcare and Indirect Cost of the Laparoscopic vs. Vaginal Approach in Benign Hysterectomy.

Authors:  María Ángeles Martínez-Maestre; Francisco Jódar-Sánchez; Ana María Calderón-Cabrera; Carmen González-Cejudo; José Manuel Silván-Alfaro; Lidia María Melero-Cortés
Journal:  JSLS       Date:  2022 Jul-Sep       Impact factor: 1.789

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.